About this trial
Reverse shoulder arthroplasty (RSA) is a well-established treatment for rotator cuff arthropathy. However, the effectiveness of RSA has not been compared to non-surgical treatment in a randomised controlled trial. Shoulder exercises may be an effective treatment for reducing pain and improving function in glenohumeral osteoarthritis. The primary aim of this trial is to examine if RSA followed by standard postsurgical rehabilitation is superior to a 12-week exercise programme in patients with rotator cuff arthropathy eligible for unilateral RSA. The investigators hypothesise that surgical intervention followed by standard rehabilitation, results in clinically relevant (14-point, on a scale from 0-100) improvement compared to the exercise intervention.
Eligibility criteria
Qualifiers
Patients 60-85 years
Eligible for RSA
Rotator cuff arthropathy according to Hamada grade 3, 4 and 5 (33)
Disqualifiers
Previous shoulder fracture (fracture of the proximal humerus or glenoid fracture)
Planned other upper extremity surgery within six months
Rheumatoid arthritis or other types of arthritis not diagnosed as primary glenohumeral OA
Cancer diagnosis and receiving chemo-, immuno- or radiotherapy
Trial design
Treatments tested in this trial
- TSA-group
- Exercise-group
Treatment groups
Sponsors and collaborators
University of Aarhus
Lead sponsor
Aarhus University Hospital
Collaborator
Tampere University Hospital
Collaborator
Aalborg University Hospital
Collaborator
Regionshospitalet Silkeborg
Collaborator
Oslo University Hospital
Collaborator
The Danish Rheumatism Association
Collaborator
Association of Danish Physiotherapists
Collaborator
Regionshospitalet Viborg, Skive
Collaborator
Esbjerg Hospital - University Hospital of Southern Denmark
Collaborator
Tartu University Hospital
Collaborator